Adherence data scheme

Pharmacists are to be paid by AstraZeneca to discuss adherence with patients who take Arimidex, Crestor, Nexium or Singulair.

Patients will be asked to fill in a questionnaire, the results of which will facilitate discussion. Pharmacists will receive £10 for each of up to three consultations per patient and a further £5 for each of three submissions of data to AstraZeneca.

Further details